Document Detail


Fifteen million people on antiretroviral treatment by 2015: treatment as prevention.
MedLine Citation:
PMID:  23188178     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
PURPOSE OF REVIEW: The declaration of the United Nations High Level meeting on AIDS in June 2011 includes 10 concrete targets, including to ensure that there are 15 million people living with human immunodeficiency virus (HIV) on antiretroviral treatment (ART) by 2015. This review examines the potential, opportunities and challenges of treatment as prevention of HIV and tuberculosis (TB) in reaching this target. RECENT FINDINGS: Although around 8 million people are on treatment, everyone living with HIV will eventually need ART to stay alive. As many as 24 million people living with HIV today are not on treatment, the majority not even being aware of their HIV infection. Expansion of a comprehensive prevention strategy including providing ART to 15 million or more people would significantly reduce HIV and TB morbidity, mortality and transmission. The challenges include ensuring human rights protections, steady drug supply, early diagnosis and linkage to care, task shifting, adherence, retention, and monitoring and evaluation. Expansion could also lead to the control and possible elimination of HIV in many places. SUMMARY: Achieving an 'AIDS-free generation' whereby deaths related to HIV are drastically reduced, people living with HIV are AIDS-free on ART, and HIV transmission is decreased, is both scientifically sound and practically feasible. The global community could reach 15 million people on ART by 2015 while expanding our vision and efforts to include diagnosis and treatment for all the 32 million people living with HIV in the future.
Authors:
Reuben Granich; Brian Williams; Julio Montaner
Related Documents :
24093098 - Emergence in western african countries of mdr-tb, focus on côte d'ivoire.
24558098 - Outcomes of a behavioral intervention to reduce hiv risk among drug-involved female sex...
23284598 - Introduction of an automated system for the diagnosis and quantification of hepatitis b...
24639068 - Where is the faith? using a cbpr approach to propose adaptations to an evidence-based h...
18432158 - Optimizing outcomes in patients with hepatitis c virus genotype 1 or 4.
18371538 - Antinucleosome antibodies as a marker of active proliferative lupus nephritis.
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2012-11-23
Journal Detail:
Title:  Current opinion in HIV and AIDS     Volume:  -     ISSN:  1746-6318     ISO Abbreviation:  Curr Opin HIV AIDS     Publication Date:  2012 Nov 
Date Detail:
Created Date:  2012-11-28     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101264945     Medline TA:  Curr Opin HIV AIDS     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Affiliation:
aUNAIDS, Geneva, Switzerland bSouth African Centre for Epidemiological Modelling and Analysis, Stellenbosch, South Africa cBritish Columbia Center for Excellence in HIV/AIDS, Vancouver, British Columbia, Canada.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  A kinetic and theoretical study of the borate catalysed reactions of hydrogen peroxide: the role of ...
Next Document:  Scaling up antiretroviral therapy in resource-limited settings: adapting guidance to meet the challe...